These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9712808)

  • 1. Protective effect of vaccination with a combination of recombinant surface antigen 1 and interleukin-12 against toxoplasmosis in mice.
    Letscher-Bru V; Villard O; Risse B; Zauke M; Klein JP; Kien TT
    Infect Immun; 1998 Sep; 66(9):4503-6. PubMed ID: 9712808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis.
    Dziadek B; Gatkowska J; Brzostek A; Dziadek J; Dzitko K; Grzybowski M; Dlugonska H
    Vaccine; 2011 Jan; 29(4):821-30. PubMed ID: 21087690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of long-lasting protective immunity against Toxoplasma gondii in BALB/c mice by recombinant surface antigen 1 protein encapsulated in poly (lactide-co-glycolide) microparticles.
    Chuang SC; Ko JC; Chen CP; Du JT; Yang CD
    Parasit Vectors; 2013 Feb; 6():34. PubMed ID: 23398973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The virulence-related rhoptry protein 5 (ROP5) of Toxoplasma Gondii is a novel vaccine candidate against toxoplasmosis in mice.
    Zheng B; Lu S; Tong Q; Kong Q; Lou D
    Vaccine; 2013 Sep; 31(41):4578-84. PubMed ID: 23928460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective efficacy induced by DNA prime and recombinant protein boost vaccination with Toxoplasma gondii GRA14 in mice.
    Pagheh AS; Sarvi S; Gholami S; Asgarian-Omran H; Valadan R; Hassannia H; Ahmadpour E; Fasihi-Ramandie M; Dodangeh S; Hosseni-Khah Z; Daryani A
    Microb Pathog; 2019 Sep; 134():103601. PubMed ID: 31212035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of protective effect of recombinant dense granule antigens GRA2 and GRA6 formulated in monophosphoryl lipid A (MPL) adjuvant against Toxoplasma chronic infection in mice.
    Golkar M; Shokrgozar MA; Rafati S; Musset K; Assmar M; Sadaie R; Cesbron-Delauw MF; Mercier C
    Vaccine; 2007 May; 25(21):4301-11. PubMed ID: 17418457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with E. coli produced recombinant T. gondii SAG1 with alum as adjuvant protect mice against lethal infection with Toxoplasma gondii.
    Petersen E; Nielsen HV; Christiansen L; Spenter J
    Vaccine; 1998 Aug; 16(13):1283-9. PubMed ID: 9682392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral immunization with a live recombinant attenuated Salmonella typhimurium protects mice against Toxoplasma gondii.
    Cong H; Gu QM; Jiang Y; He SY; Zhou HY; Yang TT; Li Y; Zhao QL
    Parasite Immunol; 2005; 27(1-2):29-35. PubMed ID: 15813720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination with replication-deficient recombinant adenoviruses encoding the main surface antigens of toxoplasma gondii induces immune response and protection against infection in mice.
    Caetano BC; Bruña-Romero O; Fux B; Mendes EA; Penido ML; Gazzinelli RT
    Hum Gene Ther; 2006 Apr; 17(4):415-26. PubMed ID: 16610929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxoplasma gondii protease inhibitor-1 (TgPI-1) is a novel vaccine candidate against toxoplasmosis.
    Cuppari AF; Sanchez V; Ledesma B; Frank FM; Goldman A; Angel SO; Martin V
    Vaccine; 2008 Sep; 26(39):5040-5. PubMed ID: 18675873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA vaccine encoding the Toxoplasma gondii bradyzoite-specific surface antigens SAG2CDX protect BALB/c mice against type II parasite infection.
    Zhang M; Zhao L; Song J; Li Y; Zhao Q; He S; Cong H
    Vaccine; 2013 Sep; 31(41):4536-40. PubMed ID: 23933373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The extracellular matrix protein mindin as a novel adjuvant elicits stronger immune responses for rBAG1, rSRS4 and rSRS9 antigens of Toxoplasma gondii in BALB/c mice.
    Sun X; Mei M; Zhang X; Han F; Jia B; Wei X; Chang Z; Lu H; Yin J; Chen Q; Jiang N
    BMC Infect Dis; 2014 Aug; 14():429. PubMed ID: 25091724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxoplasma gondii: the vaccine potential of three trivalent antigen-cocktails composed of recombinant ROP2, ROP4, GRA4 and SAG1 proteins against chronic toxoplasmosis in BALB/c mice.
    Dziadek B; Gatkowska J; Grzybowski M; Dziadek J; Dzitko K; Dlugonska H
    Exp Parasitol; 2012 May; 131(1):133-8. PubMed ID: 22445587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination with recombinant adenoviruses expressing Toxoplasma gondii MIC3, ROP9, and SAG2 provide protective immunity against acute toxoplasmosis in mice.
    Zhang D; Jiang N; Chen Q
    Vaccine; 2019 Feb; 37(8):1118-1125. PubMed ID: 30670302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxoplasma gondii: Protective immunity induced by a DNA vaccine expressing GRA1 and MIC3 against toxoplasmosis in BALB/c mice.
    Gong P; Cao L; Guo Y; Dong H; Yuan S; Yao X; Ren W; Yao L; Xu Z; Sun Q; Zhang X
    Exp Parasitol; 2016 Jul; 166():131-6. PubMed ID: 27059254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of protective immunity induced by DNA vaccination with genes encoding Toxoplasma gondii GRA17 and GRA23 against acute toxoplasmosis in mice.
    Zhu WN; Wang JL; Chen K; Yue DM; Zhang XX; Huang SY; Zhu XQ
    Exp Parasitol; 2017 Aug; 179():20-27. PubMed ID: 28625894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination of mice with the protective F3G3 antigen of Toxoplasma gondii activates CD4+ but not CD8+ T cells and induces Toxoplasma specific IgG antibody.
    Brinkmann V; Remington JS; Sharma SD
    Mol Immunol; 1993 Mar; 30(4):353-8. PubMed ID: 8096062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective immunity against Toxoplasma gondii in mice induced by a chimeric protein rSAG1/2.
    Yang CD; Chang GN; Chao D
    Parasitol Res; 2004 Jan; 92(1):58-64. PubMed ID: 14605877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Encapsulation of chimeric protein rSAG1/2 into poly(lactide-co-glycolide) microparticles induces long-term protective immunity against Toxoplasma gondii in mice.
    Chuang SC; Ko JC; Chen CP; Du JT; Yang CD
    Exp Parasitol; 2013 Aug; 134(4):430-7. PubMed ID: 23624036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective immunity against toxoplasmosis in mice induced by single-dose immunization with rSAG1/2 protein released from poly(lactide-co-glycolide) microparticles.
    Chuang SC; Chung YC; Yang CD
    Parasite; 2017; 24():5. PubMed ID: 28145222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.